References
1. Choi Y, Lee Y, Park H-S. Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease? Allergy Asthma Immunol Res . 2019;11:320-329.
2. Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol . 2015;135:676-681.
3. Wangberg H, White AA. Aspirin-exacerbated respiratory disease.Curr Opin Immunol . 2020;66:9-13.
4. Le Pham D, Lee JH, Park HS. Aspirin-exacerbated respiratory disease: an update. Curr Opin Pulm Med . 2017;23:89-96.
5. Hagan JB, Laidlaw TM, Divekar R, et al. Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma: A Systematic Review and Meta-Analysis. The journal of allergy and clinical immunology In practice . 2017;5:990-997.
6. Ban GY, Cho K, Kim SH, et al. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease. Clin Exp Allergy . 2017;47:37-47.
7. Ban G-Y, Kim S-H, Park H-S. Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E4.J Asthma Allergy . 2021;14:1219.
8. Hayashi H, Fukutomi Y, Mitsui C, et al. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med . 2020;201:1488-1498.
9. Park H. Early and late onset asthmatic responses following lysine‐aspirin inhalation in aspirin‐sensitive asthmatic patients.Clin Exp Allergy . 1995;25:38-40.
10. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.Eur Respir J . 2014;43:343-373.
11. Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics . 2013;29:15-21.
12. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics . 2011;12:1-16.
13. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.Bioinformatics . 2010;26:139-140.
14. Oliphant TE. Python for scientific computing. Computing in science & engineering . 2007;9:10-20.
15. Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics . 2017;33:3982-3984.
16. Ingenuity Pathway Analysis Systems [cited 2021 July 10]. Available from:http://www.ingenuity.com.
17. Woo SD, Luu QQ, Park HS. NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care. Front Pharmacol . 2020;11:1147.
18. Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol . 2014;5:570.
19. Spencer LA, Bonjour K, Melo RC, Weller PF. Eosinophil secretion of granule-derived cytokines. Front Immunol . 2014;5:496.
20. Singh J, Shah R, Singh D. Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases. Int Immunopharmacol . 2016;40:362-384.
21. Woska JR, Jr., Gillespie ME. SNARE complex-mediated degranulation in mast cells. J Cell Mol Med . 2012;16:649-656.
22. Shukla A, Berglund L, Nielsen L, et al. Regulated exocytosis in immune function: are SNARE-proteins involved? Respir Med . 2000;94:10-17.
23. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins.Physiol Rev . 2001;81:153-208.
24. Bouzigon E, Nadif R, Thompson EE, et al. A common variant in RAB27A gene is associated with fractional exhaled nitric oxide levels in adults. Clin Exp Allergy . 2015;45:797-806.
25. Park JS, Heo JS, Chang HS, et al. Association analysis of member RAS oncogene family gene polymorphisms with aspirin intolerance in asthmatic patients. DNA Cell Biol . 2014;33:155-161.
26. Reinke SN, Gallart-Ayala H, Gomez C, et al. Metabolomics analysis identifies different metabotypes of asthma severity. Eur Respir J . 2017;49.
27. Kim SH. Sphingosine-1-Phosphate: Biomarker, Contributor, or Target for Asthma? Allergy Asthma Immunol Res . 2019;11:299-301.
28. Ban GY, Youn DY, Ye YM, Park HS. Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease. PLoS One . 2020;15:e0240334.
29. Oyeniran C, Sturgill JL, Hait NC, et al. Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice. J Allergy Clin Immunol . 2015;136:1035-1046.
30. Petrache I, Kamocki K, Poirier C, et al. Ceramide synthases expression and role of ceramide synthase-2 in the lung: insight from human lung cells and mouse models. PLoS One . 2013;8:e62968.
31. Kim SH, Jung HW, Kim M, et al. Ceramide/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma. Allergy . 2020.
32. Wang M, Zhang N, Zheng M, et al. Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps.J Allergy Clin Immunol . 2019;144:1254-1264.
33. Na H, Lim H, Choi G, et al. Concomitant suppression of TH2 and TH17 cell responses in allergic asthma by targeting retinoic acid receptor-related orphan receptor gammat. J Allergy Clin Immunol . 2018;141:2061-2073 e2065.
34. Mastalerz L, Tyrak KE. Biomarkers for predicting response to long-term high dose aspirin therapy in aspirin-exacerbated respiratory disease. Clinical and translational allergy . 2021;11:e12048.
35. Larche M. Regulatory T cells in allergy and asthma. Chest . 2007;132:1007-1014.
36. Ben Mkaddem S, Benhamou M, Monteiro RC. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools. Front Immunol . 2019;10:811.
37. Gomez G. Current Strategies to Inhibit High Affinity FcepsilonRI-Mediated Signaling for the Treatment of Allergic Disease.Front Immunol . 2019;10:175.
38. Wesolowska-Andersen A, Seibold MA. Airway molecular endotypes of asthma: dissecting the heterogeneity. Curr Opin Allergy Clin Immunol . 2015;15:163-168.
39. Gelardi M, Iannuzzi L, Quaranta N, et al. NASAL cytology: practical aspects and clinical relevance. Clin Exp Allergy . 2016;46:785-792.
40. Heffler E, Landi M, Caruso C, et al. Nasal cytology: Methodology with application to clinical practice and research. Clin Exp Allergy . 2018;48:1092-1106.
41. Poole A, Urbanek C, Eng C, et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol . 2014;133:670-678 e612.
Table 1. Demographic data of the study subjects